GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » HH Biotechnology Holdings Co (OTCPK:HHBT) » Definitions » Enterprise Value

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Enterprise Value : $0.00 Mil (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is HH Biotechnology Holdings Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, HH Biotechnology Holdings Co's Enterprise Value is $0.00 Mil. HH Biotechnology Holdings Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2016 was $3.97 Mil. Therefore, HH Biotechnology Holdings Co's EV-to-EBIT ratio for today is 0.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, HH Biotechnology Holdings Co's Enterprise Value is $0.00 Mil. HH Biotechnology Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 was $7.12 Mil. Therefore, HH Biotechnology Holdings Co's EV-to-EBITDA ratio for today is 0.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, HH Biotechnology Holdings Co's Enterprise Value is $0.00 Mil. HH Biotechnology Holdings Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $7.95 Mil. Therefore, HH Biotechnology Holdings Co's EV-to-Revenue ratio for today is 0.00.


HH Biotechnology Holdings Co Enterprise Value Historical Data

The historical data trend for HH Biotechnology Holdings Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HH Biotechnology Holdings Co Enterprise Value Chart

HH Biotechnology Holdings Co Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.23 16.99 15.01 16.56 40.65

HH Biotechnology Holdings Co Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.12 40.65 36.71 41.43 39.62

Competitive Comparison of HH Biotechnology Holdings Co's Enterprise Value

For the Real Estate Services subindustry, HH Biotechnology Holdings Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HH Biotechnology Holdings Co's Enterprise Value Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, HH Biotechnology Holdings Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where HH Biotechnology Holdings Co's Enterprise Value falls into.



HH Biotechnology Holdings Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

HH Biotechnology Holdings Co's Enterprise Value for the fiscal year that ended in Dec. 2015 is calculated as

HH Biotechnology Holdings Co's Enterprise Value for the quarter that ended in Sep. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HH Biotechnology Holdings Co  (OTCPK:HHBT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

HH Biotechnology Holdings Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.004/3.973
=0.00

HH Biotechnology Holdings Co's current Enterprise Value is $0.00 Mil.
HH Biotechnology Holdings Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.97 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

HH Biotechnology Holdings Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.004/7.117
=0.00

HH Biotechnology Holdings Co's current Enterprise Value is $0.00 Mil.
HH Biotechnology Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.12 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

HH Biotechnology Holdings Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.004/7.953
=0.00

HH Biotechnology Holdings Co's current Enterprise Value is $0.00 Mil.
HH Biotechnology Holdings Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HH Biotechnology Holdings Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of HH Biotechnology Holdings Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Business Description

Traded in Other Exchanges
N/A
Address
No. 69 Heping North Street, C-Site, 25th - 26th Floor, Presidential Building, Heping District, Shenyang, CHN, 110003
HH Biotechnology Holdings Co is engaged in developing, producing and marketing of healthy food, supplements, medicine, and cosmetics.
Executives
Yizhao Zhang director 45 OLD MILLSTONE DRIVE, NIT 6, EAST WINDSOR NJ 08520

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Headlines

No Headlines